Drug costs hit insurers: Gilead still a buy?

Now watching

Next video starts in : 7 Play

Drug costs hit insurers: Gilead still a buy?

Drug costs hit insurers: Gilead still a buy?
Replay video
Up next

A real GoldieBox story

Unlock your personal NFL Now stream by signing in to NFL.com

Drug costs hit insurers: Gilead still a buy?

by CNBC Videos 3:12 mins

CNBC's Bertha Coombs reports which insurance stocks are feeling the pressure from high drug costs. FMHR trader Stephen Weiss advises investors to stick with Gilead.

View Comments (0)